While studies have shown that the NF-κB signaling pathway is involved in the overexpression of IL-6 in cancer cells [71,72], the role of NF-κB in IL-6 overexpression/secretion through miRNA modulation has not been thoroughly investigated. Here, NFKB1 is linked to cancer.